Log in
ASX:VRT

Virtus Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$3.20
MA: A$3.20
A$3.20
52-Week Range N/A
Volume339,634 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield6.50%
BetaN/A
Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. It provides fertility care and related specialized diagnostics, as well as day hospital services. The company offers in-vitro fertilization (IVF) services, including ovulation induction, intrauterine insemination, introcytoplasmic injection, GIFT, blastocyst culture, frozen embryo transfer, egg and semen freezing and storage, testicular biopsy, and support and counseling services, as well as donor egg, embryo, and sperm services. It also provides endocrinology, andrology, preimplantation genetic, and cytogenetic diagnostic services; and gynecological and obstetric ultrasound scanning and procedures. In addition, the company offers day hospital procedures, such as IVF, endoscopy, gynaecology, urology, dental, ophthalmic, cosmetic surgery, and plastic surgery. As of August 21, 2018, it operated through a network of 126 fertility specialists. The company was founded in 2008 and is headquartered in Greenwich, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.87 out of 5 stars


Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-2-94251722

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$267.98 million
Book ValueA$3.35 per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VRT News and Ratings via Email

Sign-up to receive the latest news and ratings for VRT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Virtus Health (ASX:VRT) Frequently Asked Questions

How were Virtus Health's earnings last quarter?

Virtus Health Ltd (ASX:VRT) released its quarterly earnings data on Tuesday, February, 19th. The company reported $0.18 EPS for the quarter.
View Virtus Health's earnings history
.

How often does Virtus Health pay dividends? What is the dividend yield for Virtus Health?

Virtus Health declared a Interim dividend on Wednesday, February 19th. Stockholders of record on Thursday, April 16th will be paid a dividend of 0.12 per share on Thursday, April 16th. This represents a dividend yield of 2.59%. The ex-dividend date of this dividend is Wednesday, March 25th.
View Virtus Health's dividend history
.

Who are some of Virtus Health's key competitors?

What other stocks do shareholders of Virtus Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus Health investors own include Barrick Gold (GOLD), VirnetX (VHC), JA Solar (JASO), Goldcorp (G), ARC Group WorldWide (ARCW), Amcor (AMC) and Ainsworth Game Technology (AGI).

Who are Virtus Health's key executives?

Virtus Health's management team includes the following people:
  • Ms. Susan Channon, CEO, MD & Director (Age 62)
  • Mr. Glenn Powers, CFO & Company Sec. (Age 59)
  • Mr. Steve Zappia, Managing Director of Queensland & Virtus Health Diagnostics (Age 60)
  • Ms. Nadia Stankovic, Managing Director of New South Wales
  • Ms. Jade Phelan, Managing Director of Victoria

What is Virtus Health's stock symbol?

Virtus Health trades on the ASX under the ticker symbol "VRT."

How big of a company is Virtus Health?

Virtus Health has a market capitalization of $0.00 and generates $267.98 million in revenue each year. Virtus Health employs 1,300 workers across the globe.

What is Virtus Health's official website?

The official website for Virtus Health is virtushealth.com.au.

How can I contact Virtus Health?

The company can be reached via phone at +61-2-94251722.

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.